Consistently, we demonstrated that doxorubicin treatment was effective at abrogating tumor growth, but chemotherapy-induced DNA damage as illustrated via γH2Ax staining did not elevate caspase-3 (apoptosis) level in ENO1-deficient HCT116 p53−/− tumors. This evidence concerns the gene CASP3 and neoplasm.